Silencing mediator of retinoic acid and thyroid hormone receptor regulates enhanced activation of signal transducer and activator of transcription 3 by Epstein-Barr virus-derived Epstein-Barr nuclear antigen 2

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

The Epstein-Barr virus (EBV)-encoded latency protein Epstein-Barr nuclear antigen 2 (EBNA2) is a nuclear transcriptional activator that is essential for EBV-induced cellular transformation. In a previous study, we demonstrated that EBNA2 interacts with signal transducer and activator of transcription 3 (STAT3), a signal transducer for an interleukin (IL)-6 family cytokine, and enhances its transcriptional activity. Here, we show that overexpression of a corepressor, silencing mediator of retinoic acid and thyroid hormone receptor (SMRT), decreases the EBNA2-mediated enhanced STAT3 activation. Furthermore, small-interfering RNA-mediated reduction of endogenous SMRT expression augments the EBNA2-mediated enhanced STAT3 activation. Importantly, EBNA2 reduces interactions between STAT3 and SMRT. These data demonstrate that EBNA2 acts as a transcriptional coactivator of STAT3 by influencing the SMRT corepressor complex. © 2009 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Ikeda, O., Togi, S., Kamitani, S., Muromoto, R., Sekine, Y., Nanbo, A., … Matsuda, T. (2009). Silencing mediator of retinoic acid and thyroid hormone receptor regulates enhanced activation of signal transducer and activator of transcription 3 by Epstein-Barr virus-derived Epstein-Barr nuclear antigen 2. Biological and Pharmaceutical Bulletin, 32(7), 1283–1285. https://doi.org/10.1248/bpb.32.1283

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free